Role of Lipid-Lowering Pharmacotherapy in Children
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Pediatric Drugs
- Vol. 2 (1) , 11-22
- https://doi.org/10.2165/00148581-200002010-00002
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Phenotype expression in familial combined hyperlipidemiaAtherosclerosis, 1997
- The genetic basis of atherosclerosisInternational Journal of Clinical and Laboratory Research, 1997
- Fat-soluble vitamin levels in familial hypercholesterolemiaThe Journal of Pediatrics, 1997
- Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trialThe Journal of Pediatrics, 1997
- Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemiaThe Journal of Pediatrics, 1996
- The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhoodAtherosclerosis, 1996
- Familial combined hyperlipidemia in children: Clinical expression, metabolic defects, and managementThe Journal of Pediatrics, 1993
- Use of cholestyramine in the treatment of children with familial combined hyperlipidemiaThe Journal of Pediatrics, 1993
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Prevalence and expression of familial combined hyperlipidemia in childhoodThe Journal of Pediatrics, 1990